Ashish Sarraju

Ashish Sarraju

Cardiology

9500 Euclid Avenue
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310.

Durability of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 with CTX310.

Journal: The New England journal of medicine

Published: August 28, 2026

Correction to: 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Correction to: 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Journal: Circulation

Published: August 03, 2026

Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

Journal: Lancet (London, England)

Published: June 13, 2026

Patient Engagement as the Rate-Limiting Step: Normalizing Value-Based Care Teams to Address CKM Treatment Gaps.

Patient Engagement as the Rate-Limiting Step: Normalizing Value-Based Care Teams to Address CKM Treatment Gaps.

Journal: JACC. Case reports

Published: June 04, 2026

Lipoprotein(a) and Outcomes in Familial Hypercholesterolemia.

Lipoprotein(a) and Outcomes in Familial Hypercholesterolemia.

Journal: European journal of preventive cardiology

Published: May 01, 2026

Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial.

Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial.

Journal: Journal of the American College of Cardiology

Published: February 13, 2026

Xanthomas: A clue to undiagnosed lipid disorders.

Xanthomas: A clue to undiagnosed lipid disorders.

Journal: Cleveland Clinic journal of medicine

Published: February 02, 2026

2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Journal: Circulation

Published: January 21, 2026

Automating Chart Review Utilizing an Artificial Intelligence-Enabled System for Assessing Transthyretin Amyloid Cardiomyopathy Trial Eligibility.

Automating Chart Review Utilizing an Artificial Intelligence-Enabled System for Assessing Transthyretin Amyloid Cardiomyopathy Trial Eligibility.

Journal: Journal of cardiac failure

Published: January 11, 2026

Identifying severe hypercholesterolemia in participants of ASCVD trials: Implications for trial conduct and opportunistic screening.

Identifying severe hypercholesterolemia in participants of ASCVD trials: Implications for trial conduct and opportunistic screening.

Journal: Journal of clinical lipidology

Published: November 12, 2025

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3.

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3.

Journal: The New England journal of medicine

Published: November 10, 2025

Lipoprotein(a) in clinical practice: What clinicians need to know.

Lipoprotein(a) in clinical practice: What clinicians need to know.

Journal: Cleveland Clinic journal of medicine

Published: November 03, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026